Search

Your search keyword '"Zéguimé A"' showing total 6 results
Start Over Author "Zéguimé A" Publication Year Range Last 3 years
6 results on '"Zéguimé A"'

1. PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial

Author

Coulibaly, Drissa, Kone, Abdoulaye K., Traore, Karim, Niangaly, Amadou, Kouriba, Bourema, Arama, Charles, Zeguime, Amatigue, Dolo, Amagana, Lyke, Kirsten E., Plowe, Christopher V., Abebe, Yonas, Potter, Gail E., Kennedy, Jessie K., Galbiati, Shirley M., Nomicos, Effie, Deye, Gregory A., Richie, Thomas L., James, Eric R., KC, Natasha, Sim, B. Kim Lee, Hoffman, Stephen L., Doumbo, Ogobara K., Thera, Mahamadou A., and Laurens, Matthew B.

Published
2022
Full Text
View/download PDF

2. Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial

Author

Sissoko, Mahamadou S, Healy, Sara A, Katile, Abdoulaye, Zaidi, Irfan, Hu, Zonghui, Kamate, Bourama, Samake, Yacouba, Sissoko, Kourane, Mwakingwe-Omari, Agnes, Lane, Jacquelyn, Imeru, Alemush, Mohan, Rathy, Thera, Ismaila, Guindo, Cheick Oumar, Dolo, Amagana, Niare, Karamoko, Koïta, Fanta, Niangaly, Amadou, Rausch, Kelly M, Zeguime, Amatigue, Guindo, Merepen A, Bah, Aissatou, Abebe, Yonas, James, Eric R, Manoj, Anita, Murshedkar, Tooba, KC, Natasha, Sim, B Kim Lee, Billingsley, Peter F, Richie, Thomas L, Hoffman, Stephen L, Doumbo, Ogobara, and Duffy, Patrick E

Published
2022
Full Text
View/download PDF

3. Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria

Author

Kayentao, Kassoum, primary, Ongoiba, Aissata, additional, Preston, Anne C., additional, Healy, Sara A., additional, Hu, Zonghui, additional, Skinner, Jeff, additional, Doumbo, Safiatou, additional, Wang, Jing, additional, Cisse, Hamidou, additional, Doumtabe, Didier, additional, Traore, Abdrahamane, additional, Traore, Hamadi, additional, Djiguiba, Adama, additional, Li, Shanping, additional, Peterson, Mary E., additional, Telscher, Shinyi, additional, Idris, Azza H., additional, Adams, William C., additional, McDermott, Adrian B., additional, Narpala, Sandeep, additional, Lin, Bob C., additional, Serebryannyy, Leonid, additional, Hickman, Somia P., additional, McDougal, Andrew J., additional, Vazquez, Sandra, additional, Reiber, Matthew, additional, Stein, Judy A., additional, Gall, Jason G., additional, Carlton, Kevin, additional, Schwabl, Philipp, additional, Traore, Siriman, additional, Keita, Mamadou, additional, Zéguimé, Amatigué, additional, Ouattara, Adama, additional, Doucoure, M’Bouye, additional, Dolo, Amagana, additional, Murphy, Sean C., additional, Neafsey, Daniel E., additional, Portugal, Silvia, additional, Djimdé, Abdoulaye, additional, Traore, Boubacar, additional, Seder, Robert A., additional, and Crompton, Peter D., additional

Published
2024
Full Text
View/download PDF

4. OA-344 Clinical development in Burkina Faso of novel malaria vaccines based on the Pfs48/45 antigen

Author

Ouedraogo, Alphonse, primary, Plieskatt, Jordan, additional, Ouedraogo, Issa N, additional, Soulama, Ben Idriss, additional, Ezinmegon, Sem, additional, Miura, Kazutoyo, additional, Naghizadeh, Mohammad, additional, Ofori, Ebenezer, additional, Diarra, Amidou, additional, Henry, Noelie, additional, Zéguimé, Amatigué, additional, Bengtsson, Karin Lövgren, additional, Reimer, Jenny M, additional, Long, Carole, additional, Sagara, Issaka, additional, Sirima, Sodiomon B, additional, Tiono, Alfred B, additional, and Thesien, Michael, additional

Published
2023
Full Text
View/download PDF

5. Safety and Efficacy of a Monoclonal Antibody against Malaria in Mali

Author

Kayentao, Kassoum, primary, Ongoiba, Aissata, additional, Preston, Anne C., additional, Healy, Sara A., additional, Doumbo, Safiatou, additional, Doumtabe, Didier, additional, Traore, Abdrahamane, additional, Traore, Hamadi, additional, Djiguiba, Adama, additional, Li, Shanping, additional, Peterson, Mary E., additional, Telscher, Shinyi, additional, Idris, Azza H., additional, Kisalu, Neville K., additional, Carlton, Kevin, additional, Serebryannyy, Leonid, additional, Narpala, Sandeep, additional, McDermott, Adrian B., additional, Gaudinski, Martin, additional, Traore, Siriman, additional, Cisse, Hamidou, additional, Keita, Mamadou, additional, Skinner, Jeff, additional, Hu, Zonghui, additional, Zéguimé, Amatigué, additional, Ouattara, Adama, additional, Doucoure, M’Bouye, additional, Dolo, Amagana, additional, Djimdé, Abdoulaye, additional, Traore, Boubacar, additional, Seder, Robert A., additional, and Crompton, Peter D., additional

Published
2022
Full Text
View/download PDF

6. Safety and Efficacy of a Monoclonal Antibody against Malaria in Mali

Author

Kassoum, Kayentao, Aissata, Ongoiba, Anne C, Preston, Sara A, Healy, Safiatou, Doumbo, Didier, Doumtabe, Abdrahamane, Traore, Hamadi, Traore, Adama, Djiguiba, Shanping, Li, Mary E, Peterson, Shinyi, Telscher, Azza H, Idris, Neville K, Kisalu, Kevin, Carlton, Leonid, Serebryannyy, Sandeep, Narpala, Adrian B, McDermott, Martin, Gaudinski, Siriman, Traore, Hamidou, Cisse, Mamadou, Keita, Jeff, Skinner, Zonghui, Hu, Amatigué, Zéguimé, Adama, Ouattara, M'Bouye, Doucoure, Amagana, Dolo, Abdoulaye, Djimdé, Boubacar, Traore, Robert A, Seder, and Peter D, Crompton

Subjects
Adult, Antimalarials, Artemether, Lumefantrine Drug Combination, Plasmodium falciparum, Headache, Humans, General Medicine, Malaria, Falciparum, Mali, Antibodies, Monoclonal, Humanized
Abstract

CIS43LS is a monoclonal antibody that was shown to protect against controlledWe conducted a phase 2 trial to assess the safety and efficacy of a single intravenous infusion of CIS43LS againstIn Part B, 330 adults underwent randomization; 110 were assigned to each trial group. The risk of moderate headache was 3.3 times as high with 40 mg of CIS43LS per kilogram as with placebo.CIS43LS was protective against

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results